From April 1, 2023 to May 12, 2023, the company has repurchased 0 shares, representing 0% for ¥0 million. With this, the company has completed the repurchase of 263,900 shares, representing 0.6% for ¥545.29 million under the buyback announced on May 11, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,009 JPY | +0.45% | -4.74% | -0.40% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.40% | 568M | |
+21.59% | 44.15B | |
+23.03% | 23.02B | |
+18.22% | 15.33B | |
+12.26% | 13.74B | |
+52.55% | 12.16B | |
-10.02% | 6.84B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.92% | 5.66B |
- Stock Market
- Equities
- 4559 Stock
- News Zeria Pharmaceutical Co., Ltd.
- Tranche Update on Zeria Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 11, 2022.